CIC Events

Metabolic Control of Cell Fate in Regeneration and Cancer
Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability
Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

The long journey to develop a drug against an “undruggable” target in cancer
Laura Soucek — Vall d´Hebron, Barcelona

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies
Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

Decoding the RAS-PI3K-YAP signalling axis in CAFs during lung cancer progression
Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.
Cristian Prieto — IBCII - Univ. Frankfurt
Past Events

Dissecting metastatic Bladder Cancer
Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”

Defining mechanisms of genomic evolution in cancer
Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond
Carlos Fernández de Larrea — Hospital Clínic de Barcelona